Cambridge Investment Research Advisors’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162K | Buy |
34,642
+100
| +0.3% | +$468 | ﹤0.01% | 3397 |
|
|
2025
Q1 | $190K | Hold |
34,542
| – | – | ﹤0.01% | 3222 |
|
|
2024
Q4 | $117K | Hold |
34,542
| – | – | ﹤0.01% | 3309 |
|
|
2024
Q3 | $98K | Hold |
34,542
| – | – | ﹤0.01% | 3274 |
|
|
2024
Q2 | $78K | Buy |
34,542
+500
| +1% | +$1.13K | ﹤0.01% | 3183 |
|
|
2024
Q1 | $75K | Buy |
34,042
+1,872
| +6% | +$4.12K | ﹤0.01% | 3179 |
|
|
2023
Q4 | $76K | Sell |
32,170
-3,500
| -10% | -$8.27K | ﹤0.01% | 3064 |
|
|
2023
Q3 | $66K | Buy |
+35,670
| New | +$66K | ﹤0.01% | 3014 |
|